{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:46:21Z","timestamp":1785876381048,"version":"3.56.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010029","name":"Taishan Scholar Foundation of Shandong Province","doi-asserted-by":"publisher","award":["tsqn201812140"],"award-info":[{"award-number":["tsqn201812140"]}],"id":[{"id":"10.13039\/501100010029","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009108","name":"Shandong University","doi-asserted-by":"publisher","award":["6010225019"],"award-info":[{"award-number":["6010225019"]}],"id":[{"id":"10.13039\/100009108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.thromres.2026.109766","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T16:18:07Z","timestamp":1782317887000},"page":"109766","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Altered IGF-1R, p70S6K, and GSK-3\u03b2 expression in PBMCs of immune thrombocytopenia patients and clinical associations"],"prefix":"10.1016","volume":"263","author":[{"given":"Xin","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningning","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.thromres.2026.109766_bb0005","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1182\/bloodadvances.2023012541","article-title":"The 2022 review of the 2019 American Society of Hematology guidelines on immune thrombocytopenia","volume":"8","author":"Neunert","year":"2024","journal-title":"Blood Adv."},{"key":"10.1016\/j.thromres.2026.109766_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2025.101300","article-title":"The new era of primary immune thrombocytopenia management in adults: a narrative review of current and emerging treatments","volume":"73","author":"Gonz\u00e1lez-L\u00f3pez","year":"2025","journal-title":"Blood Rev."},{"issue":"20","key":"10.1016\/j.thromres.2026.109766_bb0015","first-page":"2417","article-title":"The role of CD8+ T-cell clones in immune thrombocytopenia","volume":"141","author":"Malik","year":"2023","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.thromres.2026.109766_bb0020","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.immuni.2025.06.010","article-title":"More TOR: the expanding role of mTOR in regulating immune responses","volume":"58","author":"Patel","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.thromres.2026.109766_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.655731","article-title":"The mTOR-autophagy axis and the control of metabolism","volume":"9","author":"Deleyto-Seldas","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"2","key":"10.1016\/j.thromres.2026.109766_bb0030","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12992","article-title":"Abnormal expression of autophagy-related proteins in immune thrombocytopenia","volume":"93","author":"Liu","year":"2021","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.thromres.2026.109766_bb0035","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3389\/fmed.2020.00110","article-title":"Sirolimus as rescue therapy for refractory\/relapsed immune thrombocytopenia: results of a single-center, prospective, single-arm study","volume":"7","author":"Feng","year":"2020","journal-title":"Front. Med."},{"key":"10.1016\/j.thromres.2026.109766_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2025.109475","article-title":"Inhibiting mTORC1 pathway by rapamycin restores the balance of CD8+ T cell subsets and reduces CD8+ T cell-mediated platelet destruction in immune thrombocytopenia","volume":"254","author":"Ni","year":"2025","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2026.109766_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2024.156750","article-title":"The critical roles of IGFs in immune modulation and inflammation","volume":"183","author":"Wang","year":"2024","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.thromres.2026.109766_bb0050","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.immuni.2020.03.013","article-title":"Insulin-like growth factors are key regulators of T helper 17 regulatory T cell balance in autoimmunity","volume":"52","author":"DiToro","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.thromres.2026.109766_bb0055","article-title":"The role of GSK3\u03b2 in T lymphocytes in the tumor microenvironment","volume":"10","author":"A","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.thromres.2026.109766_bb0060","article-title":"Controlled signaling-insulin-like growth factor receptor endocytosis and presence at intracellular compartments","volume":"11","author":"Rieger","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.thromres.2026.109766_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mgene.2016.10.011","article-title":"Association of Insulin-like Growth Factor-1 receptor polymorphism and insulin-like growth Factor-1 plasma level with chronic immune thrombocytopenia in Chinese population","volume":"11","author":"Liu","year":"2017","journal-title":"Meta Gene"},{"issue":"22","key":"10.1016\/j.thromres.2026.109766_bb0070","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1093\/hmg\/ddt300","article-title":"IGF-1 receptor antagonism inhibits autophagy","volume":"22","author":"Renna","year":"2013","journal-title":"Hum. Mol. Genet."},{"issue":"11","key":"10.1016\/j.thromres.2026.109766_bb0075","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1080\/17474086.2021.1995347","article-title":"Immune thrombocytopenia","volume":"14","author":"Bussel","year":"2021","journal-title":"Expert Rev. Hematol."},{"issue":"17","key":"10.1016\/j.thromres.2026.109766_bb0080","doi-asserted-by":"crossref","first-page":"9666","DOI":"10.1073\/pnas.171301998","article-title":"p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD","volume":"98","author":"Harada","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.thromres.2026.109766_bb0085","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nri3198","article-title":"Regulation and function of mTOR signalling in T cell fate decisions","volume":"12","author":"Chi","year":"2012","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.thromres.2026.109766_bb0090","first-page":"1282","article-title":"Progress on the efficacy and potential mechanisms of rapamycin in the treatment of immune thrombocytopenia","volume":"27","author":"Wang","year":"2022","journal-title":"Hematology (Amsterdam, Netherlands)"},{"issue":"Supplement 1","key":"10.1016\/j.thromres.2026.109766_bb0095","doi-asserted-by":"crossref","first-page":"8404","DOI":"10.1182\/blood-2022-166345","article-title":"Rapamycin inhibits cytotoxic T lymphocytes-mediated platelet destruction in immune thrombocytopenia","volume":"140","author":"Ni","year":"2022","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.thromres.2026.109766_bb0100","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.4049\/jimmunol.1003511","article-title":"Glycogen synthase Kinase-3 is an early determinant in the differentiation of pathogenic Th17 cells","volume":"186","author":"Beurel","year":"2011","journal-title":"J. Immunol. (Baltimore, Md.: 1950)"},{"issue":"2","key":"10.1016\/j.thromres.2026.109766_bb0105","article-title":"Regulatory factors involved in Th17\/Treg cell balance of immune thrombocytopenia","volume":"71","author":"Kargar","year":"2023","journal-title":"Curr. Res. Transl. Med."},{"issue":"12","key":"10.1016\/j.thromres.2026.109766_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050909","article-title":"The ratio of Treg\/Th17 cells correlates with the disease activity of primary immune thrombocytopenia","volume":"7","author":"Ji","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.thromres.2026.109766_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.70048","article-title":"SIRT7 ameliorates Th17\/Treg imbalance by desuccinylation of STAT3 to improve immune thrombocytopenia","volume":"14","author":"Ge","year":"2025","journal-title":"Clin. Transl. Immunol."},{"issue":"6559","key":"10.1016\/j.thromres.2026.109766_bb0120","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/378785a0","article-title":"Inhibition of glycogen synthase Kinase-3 by insulin mediated by protein kinase B","volume":"378","author":"Cross","year":"1995","journal-title":"Nature"},{"issue":"22","key":"10.1016\/j.thromres.2026.109766_bb0125","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","article-title":"Updated international consensus report on the investigation and management of primary immune thrombocytopenia","volume":"3","author":"Provan","year":"2019","journal-title":"Blood Adv."},{"issue":"1","key":"10.1016\/j.thromres.2026.109766_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102345","article-title":"Immune attack on megakaryocytes in immune thrombocytopenia","volume":"8","author":"Petito","year":"2024","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2026.109766_bb0135","article-title":"Association of platelet desialylation and circulating follicular Helper T cells in patients with thrombocytopenia","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.thromres.2026.109766_bb0140","doi-asserted-by":"crossref","first-page":"7737","DOI":"10.1038\/ncomms8737","article-title":"Desialylation is a mechanism of fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia","volume":"6","author":"Li","year":"2015","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.thromres.2026.109766_bb0145","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40164-021-00214-5","article-title":"Platelet desialylation and TFH cells-the novel pathway of immune thrombocytopenia","volume":"10","author":"Chen","year":"2021","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.thromres.2026.109766_bb0150","article-title":"The role of platelet desialylation as a biomarker in primary immune thrombocytopenia: mechanisms and therapeutic perspectives","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.thromres.2026.109766_bb0155","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12935-019-0779-0","article-title":"Megakaryocytic dysfunction in immune thrombocytopenia is linked to autophagy","volume":"19","author":"Sun","year":"2019","journal-title":"Cancer Cell Int."},{"issue":"4","key":"10.1016\/j.thromres.2026.109766_bb0160","first-page":"4016","article-title":"Immune thrombocytopenia induces autophagy and suppresses apoptosis in megakaryocytes","volume":"18","author":"Liu","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.thromres.2026.109766_bb0165","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.critrevonc.2016.01.011","article-title":"Targeting autophagy as a potential therapeutic approach for immune thrombocytopenia therapy","volume":"100","author":"Shan","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"4","key":"10.1016\/j.thromres.2026.109766_bb0170","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.immuni.2020.03.013","article-title":"Insulin-like growth factors are key regulators of T helper 17 regulatory T cell balance in autoimmunity","volume":"52","author":"DiToro","year":"2020","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.thromres.2026.109766_bb0175","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.15252\/emmm.201303376","article-title":"Insulin-like growth Factor-1 stimulates regulatory T cells and suppresses autoimmune disease","volume":"6","author":"Bilbao","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.thromres.2026.109766_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.566090","article-title":"Transcriptional regulation of NK cell development by mTOR complexes","volume":"8","author":"Yang","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.thromres.2026.109766_bb0185","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1146\/annurev-immunol-020711-075024","article-title":"Regulation of immune responses by mTOR","volume":"30","author":"Powell","year":"2012","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.thromres.2026.109766_bb0190","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1038\/s41467-017-01602-4","article-title":"mTOR intersects antibody-inducing signals from TACI in marginal zone B cells","volume":"8","author":"Sintes","year":"2017","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.thromres.2026.109766_bb0195","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41467-018-02897-7","article-title":"Gimap5-dependent inactivation of GSK3\u03b2 is required for CD4+ T cell homeostasis and prevention of immune pathology","volume":"9","author":"Patterson","year":"2018","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.thromres.2026.109766_bb0200","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ni.3664","article-title":"Gsk3 is a metabolic checkpoint regulator in B cells","volume":"18","author":"Jellusova","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.thromres.2026.109766_bb0205","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.603288","article-title":"Inhibition of glycogen synthase kinase 3\u03b2 increases the proportion and suppressive function of CD19+CD24hiCD27+ Breg cells","volume":"11","author":"Li","year":"2020","journal-title":"Front. Immunol."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384826001854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384826001854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T19:59:50Z","timestamp":1785873590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384826001854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":41,"alternative-id":["S0049384826001854"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109766","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered IGF-1R, p70S6K, and GSK-3\u03b2 expression in PBMCs of immune thrombocytopenia patients and clinical associations","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109766","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109766"}}